Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 17;45(8):840-846.
doi: 10.1093/jat/bkab055.

Neonatal Exposure to Tramadol through Mother's Breast Milk

Affiliations

Neonatal Exposure to Tramadol through Mother's Breast Milk

Ashley M Gesseck et al. J Anal Toxicol. .

Abstract

Tramadol is an opioid used in the treatment of moderate to moderately severe pain. Tramadol's use during pregnancy is generally avoided and may cause some reversible withdrawal effects in neonates, and its use during lactation is not licensed by the manufacturer. A small clinical trial reported infants were exposed to <3% of a mother's tramadol dose through breast milk with no evidence of harmful effects. Presented is a case study of breast milk, neonatal urine, and neonatal oral fluid for the analysis of tramadol and its metabolites, along with the validation of a method for the analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol in breast milk. Tramadol and its metabolites were extracted by solid-phase extraction after saponification of breast milk to remove lipids. Samples were analyzed by ultra-pressure liquid chromatography-tandem mass spectrometry. To the author's knowledge, this is the first report of tramadol and its metabolites in neonatal oral fluid. The breast milk concentrations were 63, 22, and 76 ng/mL for the analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol, respectively, on day of life 12. On day of life 20, the breast milk concentrations were 1,254, 388, and 937 ng/mL for the analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol, respectively. Oral fluid concentrations were 1,011, 1,499, and 406 ng/mL for the analysis of tramadol, O-desmethyltramadol, and N-desmethyltramadol, respectively, on day of life 20. Oral fluid concentrations were similar to breast milk for tramadol, almost four times higher for O-desmethyltramadol, and less than half for N-desmethyltramadol. The absolute infant dose was calculated to be 10 μg/kg/day and 294 μg/kg/day for tramadol on day of life 12 and 20, respectively.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
GC–MS total ion chromatogram of tramadol and its metabolites in urine day of life 20 sample.
Figure 2.
Figure 2.
LC–MS-MS total ion chromatogram of tramadol and its metabolites in breast milk day of life 20 sample.

Similar articles

References

    1. Ito S. (2018) Opioids in breast milk: pharmacokinetic principles and clinical implications. The Journal of Clinical Pharmacology, 58, S151–S163. doi: 10.1002/jcph.1113 - DOI - PubMed
    1. Fríguls B., Joya X., García-Algar O., Pallás C.R., Vall O., Pichini S. (2010) A comprehensive review of assay methods to determine drugs in breast milk and the safety of breastfeeding when taking drugs. Analytical and Bioanalytical Chemistry, 397, 1157–1179. doi: 10.1007/s00216-010-3681-0 - DOI - PubMed
    1. Raisler J., Alexander C., O’Campo P. (1999) Breast-feeding and infant illness: a dose-response relationship? American Journal of Public Health, 89, 25–30. doi: 10.2105/AJPH.89.1.25 - DOI - PMC - PubMed
    1. Ito S., Lee A. (2003) Drug excretion into breast milk—overview. Advanced Drug Delivery Reviews, 55, 617–627. doi: 10.1016/S0169-409X(03)00034-6 - DOI - PubMed
    1. Sachs H.C. (2013) The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics, 132, e796–e809. doi: 10.1542/peds.2013-1985 - DOI - PubMed
-